Mesenchymal Stromal Cells Reprogram Neutrophils into Immunosuppressive Effectors via Phagocytosis and Extracellular Vesicle Transfer
This study reveals that mesenchymal stromal cells (MSCs) reprogram neutrophils into immunosuppressive effectors via oxygen-dependent phagocytosis and extracellular vesicle transfer, enabling these "programmed neutrophils" to indirectly suppress autologous T-cell responses through direct cell-cell interaction.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human immune system is a vast, intricate network designed to protect the body from invaders. It relies on different types of soldiers, each with a specific job. Some cells, known as T-cells, act as the commanders, directing the overall attack against threats like viruses or transplanted organs. Others, called neutrophils, are the foot soldiers that rush to the scene of an injury or infection to fight off bacteria and clear away debris. For a long time, scientists believed these foot soldiers were simple, short-lived fighters that only caused inflammation. However, recent discoveries show that neutrophils are surprisingly flexible; they can change their behavior and even learn to calm down the immune system if the right signals are given. This ability to switch from a fighter to a peacemaker is crucial for treating conditions where the immune system attacks the body itself, such as in severe reactions to organ transplants.
In a new study, researchers explored how mesenchymal stromal cells, a type of healing cell used in therapies, might be teaching these neutrophils to become peacemakers. These healing cells are already known to help suppress dangerous immune overreactions, but the exact way they communicate with the immune system has remained a mystery. The scientists wanted to know if these healing cells could reprogram neutrophils to stop them from fueling the fire of inflammation, and if so, how this transformation happened. They set out to watch the interaction between these cells in a controlled laboratory setting to see if the neutrophils could learn to quiet the T-cells that drive immune attacks.
The researchers began by mixing human neutrophils with these healing cells in a dish. They allowed the two types of cells to interact for several hours before removing the healing cells entirely. What they found was striking: the neutrophils that had spent time with the healing cells had changed. When these "programmed" neutrophils were placed next to activated T-cells, they successfully stopped the T-cells from multiplying and causing damage. This suppression was not because the T-cells were dying; they remained alive and healthy, but they simply refused to launch their attack. The neutrophils had effectively learned to put a brake on the immune response. Interestingly, the study showed that the healing cells did not need to stay alive to teach this lesson. Whether the healing cells were alive or had been gently turned off (apoptotic), they could still reprogram the neutrophils. However, if the healing cells were destroyed in a harsh, necrotic way, they lost this ability, suggesting that specific biological signals, rather than just the presence of cell debris, were required for the lesson to take hold.
To understand how this teaching occurred, the team looked closely at the physical interaction between the cells. They discovered that the neutrophils were actually eating pieces of the healing cells. This process, known as phagocytosis, is like a soldier swallowing a piece of a flag to understand the enemy's strategy. The researchers used a special dye that glows only when it gets inside the acidic environment of a cell's stomach, allowing them to watch the neutrophils swallow the healing cells in real time. They found that this eating process required oxygen and the cell's internal skeleton to work properly. When they blocked the neutrophils' ability to eat, the reprogramming failed. Furthermore, the more healing cells a neutrophil swallowed, the better it became at suppressing the T-cells. This suggested a direct link: the act of consuming the healing cells was what triggered the change in the neutrophil's behavior.
However, the story did not end with eating. The researchers noticed that even when they prevented the neutrophils from physically swallowing the healing cells, the neutrophils still received some of the healing cells' material. This pointed to a second method of communication involving tiny bubbles called extracellular vesicles. These are microscopic packages released by cells that carry instructions in the form of proteins and genetic material. The study showed that these vesicles, released by the healing cells, could travel through the fluid and enter the neutrophils, contributing to the reprogramming process. In fact, the researchers found that the fluid left behind by the healing cells, even without the cells themselves, was enough to change the neutrophils. This confirmed that the healing cells use a combination of being eaten and sending out these tiny instruction bubbles to teach the neutrophils their new role.
The implications of this discovery are significant for understanding how cell therapies work. The study revealed that the healing cells do not just act directly on the immune system's commanders; they also train the foot soldiers to become regulators. This training creates a new type of neutrophil that actively suppresses the immune response, helping to prevent the body from attacking itself. The researchers also observed that this process is not identical for everyone. The ability of the healing cells to reprogram neutrophils varied depending on the specific people who donated the cells, highlighting that individual biology plays a role in how well this therapy might work. By uncovering this hidden pathway, where healing cells reprogram neutrophils through eating and vesicle transfer, the study provides a clearer picture of how these therapies calm the immune system. It suggests that the success of these treatments may depend on the neutrophils' ability to learn and adapt, offering new ways to measure and improve these life-saving medical interventions.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.